Synthesis and Biological Evaluation of Methoxypolyethylene-Glycol-Substituted Abiraterone Derivatives as Potential Antiprostate Cancer Agents
Molecular Pharmaceutics · 2024
DOI: 10.1021/acs.molpharmaceut.3c01188 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Shuai Meng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Can…. Hauptthemen laut MEDLINE: Androstenes, Prostatic Neoplasms, Antineoplastic Agents, Polyethylene Glycols. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Tianjin Municipal Science and Technology Bureau, Chinese Academy of Medical Sciences, National Natural Science Foundation of China.
Abstract (Originalsprache)
Globally, prostate cancer is the most commonly diagnosed tumor and a cause of death in older men. Abiraterone, an orally administered irreversible CYP17 inhibitor, is employed to treat prostate cancer. However, abiraterone has several clinical limitations, such as poor water solubility, low dissolution rate, low bioavailability, and toxic side effects in the liver and kidney. Therefore, there is a need to identify high-efficiency and low-toxicity water-soluble abiraterone derivatives. In this work, we aimed to design and synthesize a series of abiraterone derivatives by methoxypoly(ethylene glycol) (mPEG) modification. Their antitumor activities and toxicology were analyzed in vitro and in vivo. The most potent compound, 2e, retained the principle of action on the CYP17 enzyme target and significantly improved the abiraterone water solubility, cell permeability, and blood safety. No significant abnormalities were observed in toxicology. mPEG-modification significantly improved abiraterone's antitumor activity and efficiency while reducing the associated toxic effects. The finding will provide a theoretical basis for future clinical application of mPEG-modified abiraterone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Can…
- Tianjin Key Laboratory of Biomedical Materials, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300192, People's Republic of China.
- Institute of Traditional Chinese Medicine, Tianjin Key Laboratory of Chinese Medicine Pharmacology, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, People's Republic of China.
ORCID-Profile: Tianjun Liu
Förderung
- Tianjin Municipal Science and Technology Bureau
- Chinese Academy of Medical Sciences
- National Natural Science Foundation of China
- Tianjin Municipal Education Commission
- Tianjin Medical Key Discipline (Specialty) Construction Project
- Tianjin Medical University Cancer Hospital
Zitieren
APA
Meng, S., Zhu, N., Han, D., Li, B., Zhang, X., Zhang, J., & Liu, T. (2024). Synthesis and Biological Evaluation of Methoxypolyethylene-Glycol-Substituted Abiraterone Derivatives as Potential Antiprostate Cancer Agents. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c01188
Vancouver
Meng S, Zhu N, Han D, Li B, Zhang X, Zhang J, et al. Synthesis and Biological Evaluation of Methoxypolyethylene-Glycol-Substituted Abiraterone Derivatives as Potential Antiprostate Cancer Agents. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.3c01188
BibTeX
@article{Meng2024,
author = {Meng, Shuai and Zhu, Na and Han, Di and Li, Bole and Zhang, Xiaolong and Zhang, Jie and Liu, Tianjun},
title = {Synthesis and Biological Evaluation of Methoxypolyethylene-Glycol-Substituted Abiraterone Derivatives as Potential Antiprostate Cancer Agents},
journal = {Molecular Pharmaceutics},
year = {2024},
doi = {10.1021/acs.molpharmaceut.3c01188}
}
EUVIMED